Alcon Q1 2026 Sales Rise 10% as New Eye-Care Products Power Growth and $1.5 Billion Buyback
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alcon ( (CH:ALC) ) has shared an update.
On May 5, 2026, Alcon reported first-quarter 2026 results showing net sales of $2.7 billion, up 10% year-on-year on a reported basis and 6% in constant currency, driven by strong uptake of recent launches such as Unity VCS and CS, PanOptix Pro, Tryptyr and Precision7. Despite revenue growth and an improved core operating margin of 21.2%, reported operating margin declined to 10.9% and diluted EPS fell to $0.39, while core diluted EPS rose to $0.85, supported by stable free cash flow of $279 million, a CHF 0.28 per-share dividend approval and a new $1.5 billion three-year share repurchase authorization that underscores management’s confidence and capital-return focus.
Segment data show broad-based gains, with Surgical sales advancing 10% to $1.46 billion and Vision Care growing through higher contact lens and ocular health revenues versus the prior-year quarter. The combination of innovation-led top-line expansion, resilient cash generation and stepped-up shareholder distributions positions Alcon to reinforce its competitive standing in global eye care markets, even as margin pressures highlight ongoing cost and mix challenges that investors will watch in subsequent quarters.
The most recent analyst rating on (CH:ALC) stock is a Sell with a CHF55.00 price target. To see the full list of analyst forecasts on Alcon stock, see the CH:ALC Stock Forecast page.
More about Alcon
Alcon Inc. is a global leader in eye care, listed on SIX and NYSE, with principal executive offices in Fribourg, Switzerland. The company operates across Surgical and Vision Care segments, offering implantables, consumables, equipment, contact lenses and ocular health products, targeting both ophthalmic surgeons and consumers worldwide.
Average Trading Volume: 1,022,312
Technical Sentiment Signal: Sell
Current Market Cap: CHF28.94B
Find detailed analytics on ALC stock on TipRanks’ Stock Analysis page.
